Abbott Laboratories Aktie
WKN: 850103 / ISIN: US0028241000
02.04.2024 15:38:10
|
Abbott Says FDA Approves First-of-Its-Kind TriClip Transcatheter Edge-to-edge Repair System
(RTTNews) - Abbott Laboratories (ABT) announced Tuesday that the U.S. Food and Drug Administration (FDA) has approved the company's first-of-its-kind TriClip transcatheter edge-to-edge repair (TEER) system that's specifically designed for the treatment of tricuspid regurgitation (TR), or a leaky tricuspid valve.
This approval follows the recent recommendation of the Circulatory System Devices Panel of the Medical Devices Advisory Committee for the FDA, whose vote confirmed 13 to 1, that the benefits of TriClip outweighed the risks.
The tricuspid valve controls blood as it flows from the heart's right atrium to the right ventricle. TR occurs when the valve doesn't close properly, causing a leak and allowing blood to flow backward in the heart. Delivered through a vein in the leg, TriClip's TEER technology works by clipping together a portion of the leaflets - or flaps of tissue - to repair the tricuspid valve and help blood flow in the right direction without the need for open-heart surgery.
On average, people who receive TriClip only need one day in the hospital before they recover and can return home.
TriClip leverages the same clip-based technology as Abbott's leading MitraClip device.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Abbott Laboratoriesmehr Nachrichten
18.07.25 |
Minuszeichen in New York: So entwickelt sich der S&P 500 am Freitagnachmittag (finanzen.at) | |
18.07.25 |
NASDAQ-Handel: NASDAQ Composite legt zum Start des Freitagshandels zu (finanzen.at) | |
17.07.25 |
Börse New York: NASDAQ Composite beendet den Handel im Plus (finanzen.at) | |
17.07.25 |
Zuversicht in New York: S&P 500 zeigt sich letztendlich fester (finanzen.at) | |
17.07.25 |
Gewinne in New York: NASDAQ Composite legt zu (finanzen.at) | |
17.07.25 |
S&P 500 aktuell: Am Nachmittag Pluszeichen im S&P 500 (finanzen.at) | |
17.07.25 |
Aufschläge in New York: S&P 500 am Donnerstagmittag fester (finanzen.at) | |
17.07.25 |
Gute Stimmung in New York: NASDAQ Composite verbucht mittags Zuschläge (finanzen.at) |
Analysen zu Abbott Laboratoriesmehr Analysen
Aktien in diesem Artikel
Abbott Laboratories | 107,00 | 0,32% |
|